4,5,6,7-Tetrahydropyrazolo[1,5-a]pyridine-3-carboxaldehyde, 95.0%, 250mg

2-(3-Methoxyphenyl)propan-2-amine hydrochloride, 250mg

Palladium sulfate, 99%, 250mg

Éther diméthylique de dipropylèneglycol, min 99%, pour la synthèse, 2,5L, emballage plastique.

N-(2,4-Difluorophenyl)-4,4-dimethyl-3-oxopentanamide, 95.0%, 10g

Calcium carbonate (precipitated), 98.0%, 5kg

3,3-Dimethylpiperidine hydrochloride, 97.0%, 100mg

(S)-METHYL 2-(N-((2'-(1H-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL)METHYL)PENTANAMIDO)-3-METHYLBUTANOATE, 95%, 100g

(R)-5-Chloro-2,3-dihydro-1H-inden-1-amine, 95.0%, 1g

1-O-TOLYLPYRAZOLE, 97.0%, 5g

4-(p-Tolyl)butyric Acid>98.0%(GC)(T)5g

1-(2-FLUORO-6-METHOXYPHENYL)ETHAN-1-AMINE, 95%, 1g

5-Nitro-1,2-benzisoxazole, 95.0%, 100mg